TrialClinical and experimental nephrology2020

Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairment.

Yuji Kumagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.